GenomaA Biotech
PrivateMomentum
Top 50%
of companies Caplight tracks
Company Overview
GenomaA Biotech is a biotechnology company that provides molecular biology services, including genetic sequencing and DNA species identification for the agribusiness, environmental, and industrial sectors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Environmental Monitoring, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GenomaA Biotech Comparables
Compare GenomaA Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MetaGen Soluções Moleculares | 88% | |
| GoGenetic | 86% | |
| B4A | 83% |
GenomaA Biotech Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors grew 159% MoM, reaching 2.5K.
- Apr 20, 2026
Monthly visitors increased 303% MoM.
GenomaA Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about GenomaA Biotech's valuation, stock price, and market status.
Is GenomaA Biotech a public or private company?
GenomaA Biotech is a private company.
What is the current stock price of GenomaA Biotech?
GenomaA Biotech is a private company with no public stock price. Caplight tracks GenomaA Biotech's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is GenomaA Biotech worth (valuation)?
Valuation information for GenomaA Biotech is not publicly available.
Can I buy GenomaA Biotech stock?
GenomaA Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was GenomaA Biotech's last funding round?
Funding round information for GenomaA Biotech is not publicly available.
Who are the main investors in GenomaA Biotech?
Investor information for GenomaA Biotech is not publicly disclosed.
Will GenomaA Biotech IPO soon?
No public IPO plans have been announced for GenomaA Biotech.
How can I track GenomaA Biotech secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor GenomaA Biotech's secondary market activity and sign up for updates.